Doris Howell

Doris Howell, RN, PhD

Dr. Doris Howell was trained as a health services researcher and is now also focused on clinical intervention research. The goal of Dr. Howell's research program is to improve the patient's experience of cancer care, through health intervention research focused on better care delivery systems and clinical interventions for complex symptoms (fatigue, breathlessness, pain). Her main focus of intervention research is on understanding how psychological factors such as beliefs influence symptom response and adaptation to illness and how these might be modified through behavioral self-management interventions. Additionally, the efficacy and effectiveness of nurse-led behavioral self-management interventions in reducing symptom distress is a clinical research focus.

Dr. Howell also has an active health service research program focused on knowledge translation of best practices in care delivery, specifically the application of chronic disease self-management for survivorship. The testing of routine collection of Patient-Reported Outcomes (PRO) and their use in clinical practice to improve care quality and patient experience of cancer will enable this research.

Her research expertise includes qualitative and quantitative methods, with specific expertise in qualitative methods (hermeneutic phenomenology) and mixed-method study designs.

Dr. Howell leads standards and guideline development and is a member of the national distress management implementation team under the Canadian Partnership Against Cancer. Dr. Howell has a leadership role in Cancer Care Ontario in Patient-Reported Outcomes.

Eur J Cancer. 2017 Apr 13;78:53-60
Kane E, Howell D, Smith A, Crouch S, Burton C, Roman E, Patmore R
Sarcoma. 2017;2017:1837475
Lewin J, Thompson K, Bae S, Desai J, Strong R, Caruso D, Howell D, Herschtal A, Sullivan M, Orme L
J Clin Oncol. 2016 Jan 20;34(3_suppl):183
Alton D, Song Y, Farzanfar D, Krys O, Yoannidis T, Milne R, Habbous S, Brown MC, Vennettilli A, Shepherd FA, Leighl NB, Hope AJ, Howell D, Jones JM, Selby P, Xu W, Goldstein DP, Giuliani ME, Liu G
J Clin Oncol. 2016 Jan 20;34(3_suppl):144
Brown C, Perez Cosio A, Leung Y, Lagrotteria A, Liang M, Gill G, Wong L, Sinnesael K, Noronha C, Willing S, Bell EN, Vennettilli A, Edwards J, Pater JL, Howell D, Kassam Z, Liu G, Hay AE
Br J Haematol. 2017 Feb 01;:
Howell D, Smith A, Appleton S, Bagguley T, Macleod U, Cook G, Patmore R, Roman E
Clin Lung Cancer. 2016 Dec 28;:
Labbé C, Leung Y, Silva Lemes JG, Stewart E, Brown C, Cosio AP, Doherty M, O'Kane GM, Patel D, Cheng N, Liang M, Gill G, Rett A, Naik H, Eng L, Mittmann N, Leighl NB, Bradbury PA, Shepherd FA, Xu W, Liu G, Howell D
Support Care Cancer. 2017 Jan 05;:
Howell D, Harth T, Brown J, Bennett C, Boyko S
Curr Oncol. 2016 Dec;23(6):e546-e555
Naik H, Qiu X, Brown MC, Eng L, Pringle D, Mahler M, Hon H, Tiessen K, Thai H, Ho V, Gonos C, Charow R, Pat V, Irwin M, Herzog L, Ho A, Xu W, Jones JM, Howell D, Liu G
J Popul Ther Clin Pharmacol. 2016 Sep 13;23(3):e196-e204
Naik H, Qiu X, Brown MC, Mahler M, Hon H, Tiessen K, Thai H, Ho V, Gonos C, Charow R, Pat V, Irwin M, Herzog L, Ho A, Xu W, Howell D, Seung SJ, Liu G, Mittmann N



RBC Chair, Oncology Nursing Research, University Health Network (Princess Margaret Hospital)
Adjunct Scientist, Cancer Care Ontario(CCO), Toronto
Co-Director of On-PROST (Ontario-Patient-Reported Outcomes on Symptoms and Toxicity), CCO
Associate Professor, Lawrence Bloomberg Faculty of Nursing, University of Toronto
Cross-Appointment, Dalla Lana School of Public Health, University of Toronto